Startup India Government of India
Xcelent Pharmaceuticals Private Limited
Xcelent Pharmaceuticals Private Limited - pharma in Noida, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.66 Cr
▲ 86% YoY
Net profit · FY 2025
₹1.34 Lakh
Net margin 0.5%
EBITDA · FY 2025
₹6.52 Lakh
EBITDA margin 2.5%
Authorised capital
₹4 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹42 Lakh
Secured borrowings
Company age
5 yrs
Est. 2021
Directors on board
3
As per MCA filings
About Xcelent Pharmaceuticals Private Limited
Data last updated:
Xcelent Pharmaceuticals Private Limited is a private limited company based in Noida, Uttar Pradesh, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 January 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24230UP2021PTC140979. Its GSTIN is 09AAACX3561E1ZD (Uttar Pradesh).
The company has an authorised share capital of ₹4 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Shikha Sharma and Premlata Rastogi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Cs – 6/1203 Supertech Capetown Sector 74, Noida, Uttar Pradesh, India – 201301.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.66 Cr, a growth of 86% compared to the previous year. For the same year it recorded a net profit of ₹1.34 Lakh (net margin 0.5%) and EBITDA of ₹6.52 Lakh (EBITDA margin 2.5%). Revenue has grown at a compounded annual rate (CAGR) of 44% over three years.
As per MCA filings, the company has open charges of ₹42 Lakh on record.
Xcelent Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-28-0017865).
Company details
CIN U24230UP2021PTC140979
Registration Number 140979
Incorporation Date 30 January 2021
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-UP-28-0017865
Recognitions & Rankings of Xcelent Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-UP-28-0017865
Contact details
Xcelent Pharmaceuticals Private Limited's registered office is in Noida, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressCs – 6/1203 Supertech Capetown Sector 74, Noida, Uttar Pradesh, India – 201301
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Xcelent Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Xcelent Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Xcelent Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Xcelent Pharmaceuticals Private Limited, buy the company report.
Financials of Xcelent Pharmaceuticals Private Limited
FY 2025 filings availableXcelent Pharmaceuticals Private Limited reported revenue of ₹2.66 Cr (up 86% YoY) for FY 2025.
Revenue · FY 2025
₹2.66 Cr ▲ 86%
Net profit · FY 2025
₹1.34 Lakh margin 0.5%
EBITDA · FY 2025
₹6.52 Lakh margin 2.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 86%
3 years · compounded
▲ 44%
EBITDA CAGR growth
1 year
▲ 447%
3 years · compounded
▲ 147%
Revenue has grown at a compounded annual rate (CAGR) of 44% over three years, including 86% growth in the latest year. EBITDA rose 447% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.52 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.34 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.5% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Xcelent Pharmaceuticals Private Limited, buy the company report.
Board of directors of Xcelent Pharmaceuticals Private Limited
Xcelent Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shikha Sharma | Director | 12 Aug 2023 | 3 Years 2 Months | Current |
| Premlata Rastogi | Director | 30 Jan 2021 | 5 Years 8 Months | Current |
| Ram Lal Rastogi | Director | 30 Jan 2021 | 5 Years 8 Months | Current |
Peer comparison
Xcelent Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zaria Pharmaceuticals Private Limited | ₹2.69 Cr (FY 2025) | -20.0% | Thane, Maharashtra, India | |||
| Synoglad Pharmaceuticals Private Limited | ₹2.67 Cr (FY 2016) | 8.0% | Jaipur, Rajasthan, India | |||
| Rangwani Pharmaceuticals Private Limited | ₹2.67 Cr (FY 2024) | 16.0% | Bhopal, Madhya Pradesh, India | |||
| Xcelent Pharmaceuticals Private Limitedthis company | ₹2.66 Cr (FY 2025) | ₹1.34 Lakh | 0.5% | 86.0% | Noida, Uttar Pradesh, India | |
| Nark Pharmaceuticals Private Limited | ₹2.64 Cr (FY 2025) | 3.0% | Ernakulam, Kerala, India | |||
| Diancecht Pharmaceuticals Private Limited | ₹2.61 Cr (FY 2023) | 40.0% | Chandigarh, India |
To see the full peer comparison of Xcelent Pharmaceuticals Private Limited, buy the company report.
Auditor
Xcelent Pharmaceuticals Private Limited is audited by MADAN KUMAR & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MADAN KUMAR & ASSOCIATES | FY 2023 | 088822 |
Shareholding
The shareholding of Xcelent Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Xcelent Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹42 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Mar 2024 | 100892421 | State Bank of India | ₹42 Lakh | Open |
To see the full charge records of Xcelent Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Xcelent Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Xcelent Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Xcelent Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAACX3561E1ZD | Uttar Pradesh | Active | 04 Feb 2021 |
To see the full GST registrations and return filing status of Xcelent Pharmaceuticals Private Limited, buy the company report.
Recent activity
Xcelent Pharmaceuticals Private Limited has 4 board changes on record since 2021: 3 appointments and 1 cessation. The latest: Avinash Kumar Singh ceased to be Director on 26 Oct 2023.
AGM
Xcelent Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with State Bank Of India of Rs. 42.00 Lakh registered on 13 Mar 2024 with Charge ID 100892421 was modified on 28 Apr 2025.
Filing
Xcelent Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Charges
A charge with State Bank Of India amounted to Rs. 42.00 Lakh with Charge ID 100892421 was registered on 13 Mar 2024.
Ceased
Avinash Kumar Singh ceased to be Director.
Appointed
Shikha Sharma was appointed as Director.
Appointed
Premlata Rastogi was appointed as Director.
Appointed
Ram Lal Rastogi was appointed as Director.
Incorporation
30 Jan 2021
Xcelent Pharmaceuticals Private Limited was registered on 30 Jan 2021 with Roc Kanpur & aged 5 years 8 months as per MCA records.
Frequently asked questions
Xcelent Pharmaceuticals is an active private limited company based in Noida, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 January 2021 (5+ years old) and is registered under CIN U24230UP2021PTC140979.
Xcelent Pharmaceuticals has 3 current directors:
- Shikha Sharma - Director
- Premlata Rastogi - Director
- Ram Lal Rastogi - Director
The latest financial statements of Xcelent Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Xcelent Pharmaceuticals is 09AAACX3561E1ZD, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Xcelent Pharmaceuticals is U24230UP2021PTC140979. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Xcelent Pharmaceuticals was incorporated on 30 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Xcelent Pharmaceuticals by revenue are Zaria Pharmaceuticals Private Limited, Synoglad Pharmaceuticals Private Limited, Rangwani Pharmaceuticals Private Limited, Nark Pharmaceuticals Private Limited, Diancecht Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Avinash Kumar Singh ceased to be Director on 26 Oct 2023. Shikha Sharma was appointed as Director on 12 Aug 2023. Premlata Rastogi was appointed as Director on 30 Jan 2021. Xcelent Pharmaceuticals has 4 board changes on record in total.
Yes, Xcelent Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Xcelent Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-28-0017865).
The registered office of Xcelent Pharmaceuticals is at Cs – 61203 Supertech Capetown Sector 74, Noida, Uttar Pradesh, India – 201301.